72
Pharma & HealthcareBuy
Kotak Healthcare
Kotak · Direct–Growth · rank #4 of 19 by Smart Score
Data updated
Trailing returns
1 Year
33.1%
+32.3% vs index
3 Years
—
5 Years
—
Since launch
23.7%
Year-by-year performance
2024
+41.9%+26.2% vs index
2025
-5.8%-13.5% vs index
2026
+36.3%+35.4% vs index
Why this score
Kotak Healthcare scores 72/100 — #4 of 19 Pharma & Healthcare fund (Buy). It stands out for sharpe ratio and alpha — beating 84% of peers on sharpe ratio. It has no major weak spot vs the category.
Each bar shows the fund's percentile vs Pharma & Healthcare peers — a longer bar beats more of the category.
Sharpe ratio1.17 · 84th percentile in category
Alpha14.79 · 97th percentile in category
1Y return33.09% · 97th percentile in category
Sortino ratio1.67 · 70th percentile in category
Volatility14.64 · 59th percentile in category
Expense ratio1.03% · 58th percentile in category
Top holdings
1.Sun Pharmaceutical Industries Ltd13.42%
2.Divi's Laboratories Ltd10.23%
3.Ami Organics Ltd4.88%
4.Molbio Diagnostics Ltd.4.74%
5.Torrent Pharmaceuticals Ltd4.29%
34 disclosed equity positions · portfolio as of Oct 2026 · weights are % of total corpus.